Stratify the most appropriate patients for Dexcom technology

Learn about our free-of-charge partnership with Promatica Digital to assess your local patient databases and help identify target patient cohorts for real-time continuous glucose monitoring (rtCGM).

Who is Promatica Digital?


Promatica Digital is a software and service provider and NHS approved partner for over 25 years. 

A Data Protection Impact Assessment is in place between Promatica Digital and the NHS, and further information will be provided about this at set-up.

Promatica Digital are an industry leader in providing datadriven innovations that optimise patient outcomes, reduce variation in care quality, and support a sustainable health and social care system. Their founding principles align closely with the NHS Long Term Plan.


Promatica Digital Solutions

Formatted Block Title

What is on offer?

What is on offer?

Dexcom has teamed up with Promatica Digital to set up their PRISM tool in your local ICS.

The PRISM tool uses customisable patient markers to provide prescribers in your ICS with the clarity to readily identify and authorise priority diabetics who require intervention with rtCGM, and see real-time progress updates in dashboard format.

Promatica can then provide expert clinicians to implement the service.

This service is fully funded by Dexcom.

What insights does the PRISM tool identify?

The Promatica Digital PRISM tool is designed to review your patient databases and find patients who meet certain criteria and parameters. These parameters can be customised according to your local needs and targets.

Once patient cohorts have been identified, the PRISM tool enables clinicians to review patients and invite them for further intervention, such as information about rtCGM and/or follow-up discussions during upcoming diabetes/HbA1c review appointments.

Does a Promatica Digital Partnership sound of interest?

Please contact our Market Access team for further information